Montelukast for Patients With Obstructive Sleep Apnea Syndrome (MONTSAS)
Impact of Blocked Cysteinyl Leukotriene Pathway on Endothelial Function in Patients With Obstructive Sleep Apnea Syndrome: Multicenter Randomized Placebo Controlled Crossover Trial
Sponsor: Act For Chronic Diseases
Terminated
lack of recruitment
This PHASE3 trial investigates Sleep Apnea, Obstructive and is currently terminated or withdrawn. Act For Chronic Diseases leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Mar 2021 — Jul 2024 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE3
▶ Show 5 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Apr 2019 — Feb 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Feb 2019 — Apr 2019 [monthly]
Not Yet Recruiting PHASE3
-
Nov 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Act For Chronic Diseases
- Direction Générale de l'Offre de Soins
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .